Instinct Bio Technical Co. Holdings Inc. BIOT

website

An integrated regenerative medicine and longevity company focused on the research, manufacturing, an...

Price0.187

Market Cap5.47 M

Float12.38 M

CountryUS

SectorConsumer Defensive

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

BIOT Instinct Bio Technical Co. Holdings Inc.

Price$0.19

Company About

An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.

Sector

Consumer Defensive

Industry

Household & Personal Products

Country

Exchange

NASDAQ

Vol Avg.

408.4 K

Inst Own

24.800%

Float & OS

12.38 M / 28.79 M

Cash/Shr

Market Cap & Ev

5.47 M / N/A

Short Interest

0.9%

Borrow Rate

6.1682%

Days to Cover

Overall Offering Risk

Warrant Exercise Risk

Research Report

Customize research

Recent Articles (8)

View All

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Globe Newswire

Sep 4, 2026, 7:00 AM

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

Globe Newswire

Aug 10, 2026, 7:00 AM

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

Globe Newswire

Jul 29, 2026, 10:28 AM

Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker “BIOT” on July 24, 2026

Globe Newswire

Jul 23, 2026, 4:15 PM

Biotech Acquisition Company Announces Liquidation

Globe Newswire

Feb 1, 2023, 7:50 PM

Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension Amendment

PRNewswire

Jan 4, 2023, 5:51 PM

Blade Therapeutics to Participate in "Drug Development in Pulmonary Medicine" Panel Discussion at 2022 BTIG Biotechnology Conference

Business Wire

Aug 1, 2022, 8:00 AM

Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement

PRNewswire

Jun 13, 2022, 8:06 AM

Recent Filings

View All

Type	Title	Date Released

Earnings

No earnings availableNo calendar earnings available for BIOT

Related Consumer Defensive stocks

All tickers